Clinical Trial

Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Individuals living with Long COVID often experiencing a degree of undue fatigue after physical or cognitive exertion secondary to the condition, timed post-exertional malaise 9PEM). This trial aims to explore the efficacy of creatine monohydrate in managing PEM
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-26.
Trial Details
NCT Number NCT06992414
Lead Sponsor University of Calgary
Conditions Long COVID Fatigue
Enrollment 24 participants
Start Date 2025-07-02
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-31